Vivekananda Bal, Moo Sun Hong, Jacqueline M. Wolfrum, Paul W. Barone, Stacy L. Springs, Anthony J. Sinskey, Robert M. Kotin and Richard D. Braatz*,
{"title":"An Integrated Experimental and Modeling Approach for Crystallization of Complex Biotherapeutics","authors":"Vivekananda Bal, Moo Sun Hong, Jacqueline M. Wolfrum, Paul W. Barone, Stacy L. Springs, Anthony J. Sinskey, Robert M. Kotin and Richard D. Braatz*, ","doi":"10.1021/acs.cgd.4c0172010.1021/acs.cgd.4c01720","DOIUrl":null,"url":null,"abstract":"<p >Crystallization of proteins, specifically proteins of medical relevance, is performed for various reasons, such as to understand the protein structure and to design therapies. Obtaining kinetic constants in rate laws for nucleation and growth of advanced biotherapeutics such as capsids, an assembly of macromolecules, is challenging and essential to the design of crystallization processes. In this work, coupled population balance and species balance equations are developed to extract nucleation and growth kinetics for the crystallization of recombinant adeno-associated virus (rAAV) capsids. A comparison of model results with that of experimental data for capsid crystallization in a hanging-drop vapor diffusion system shows that the slow rate of vapor diffusion from the droplet controls the initial nucleation and growth processes, and the capsid nucleation occurs via heterogeneous nucleation in the microdroplet. Results also show that the capsids, which are of very high molecular weight (∼3.6 MDa), have a similar tendency to nucleate as small organic molecules such as glycine (∼75 Da), low-molecular-weight proteins, and small-molecule active pharmaceutical ingredients due to their ball-shaped outer structure/shape. Capsids also show a prolonged nucleation period as for proteins and other macromolecules but have a slow growth rate with a growth rate prefactor seven orders of magnitude smaller than that of lysozyme. The capsid crystal growth rate is weakly sensitive to supersaturation compared to lysozyme and is limited by the transport of capsids due to slow Brownian motion resulting from the very high molecular weight.</p><p >We developed a mathematical model based on population balance equation and compared the simulation results with the in-house experimental measurements for temporal evolution of crystal growth rate, crystal size distribution, total number density, total length, total radius, total surface area, and total volume.</p>","PeriodicalId":34,"journal":{"name":"Crystal Growth & Design","volume":"25 11","pages":"3687–3696 3687–3696"},"PeriodicalIF":3.4000,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/epdf/10.1021/acs.cgd.4c01720","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Crystal Growth & Design","FirstCategoryId":"92","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.cgd.4c01720","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Crystallization of proteins, specifically proteins of medical relevance, is performed for various reasons, such as to understand the protein structure and to design therapies. Obtaining kinetic constants in rate laws for nucleation and growth of advanced biotherapeutics such as capsids, an assembly of macromolecules, is challenging and essential to the design of crystallization processes. In this work, coupled population balance and species balance equations are developed to extract nucleation and growth kinetics for the crystallization of recombinant adeno-associated virus (rAAV) capsids. A comparison of model results with that of experimental data for capsid crystallization in a hanging-drop vapor diffusion system shows that the slow rate of vapor diffusion from the droplet controls the initial nucleation and growth processes, and the capsid nucleation occurs via heterogeneous nucleation in the microdroplet. Results also show that the capsids, which are of very high molecular weight (∼3.6 MDa), have a similar tendency to nucleate as small organic molecules such as glycine (∼75 Da), low-molecular-weight proteins, and small-molecule active pharmaceutical ingredients due to their ball-shaped outer structure/shape. Capsids also show a prolonged nucleation period as for proteins and other macromolecules but have a slow growth rate with a growth rate prefactor seven orders of magnitude smaller than that of lysozyme. The capsid crystal growth rate is weakly sensitive to supersaturation compared to lysozyme and is limited by the transport of capsids due to slow Brownian motion resulting from the very high molecular weight.
We developed a mathematical model based on population balance equation and compared the simulation results with the in-house experimental measurements for temporal evolution of crystal growth rate, crystal size distribution, total number density, total length, total radius, total surface area, and total volume.
期刊介绍:
The aim of Crystal Growth & Design is to stimulate crossfertilization of knowledge among scientists and engineers working in the fields of crystal growth, crystal engineering, and the industrial application of crystalline materials.
Crystal Growth & Design publishes theoretical and experimental studies of the physical, chemical, and biological phenomena and processes related to the design, growth, and application of crystalline materials. Synergistic approaches originating from different disciplines and technologies and integrating the fields of crystal growth, crystal engineering, intermolecular interactions, and industrial application are encouraged.